Oligometastatic cancer is defined as a clinical state of metastatic disease that is limited to “oligo” or few metastatic lesions as identified by imaging. Conceptualized in the 1990s by Drs. Hellman and Weichselbaum, it has now become an accepted condition in the natural history of most solid malignancies
Technical challenges of linac-based stereotactic ablative body radiotherapy: short review for non-radiation oncologists
Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
Treatment paradigms for oligometastatic pediatric cancers: a narrative review with a focus on radiotherapy approaches
The series “Oligometastasis- Fallacy or Real Deal?” was commissioned by the editorial office, Annals of Palliative Medicine without any sponsorship or funding. Simon Lo, Michael Milano, Tithi Biswas and Charles B. Simone, II served as the unpaid Guest Editors for the series.